WO2013189265A1 - Procédé, système et kit de détection de la concentration en ion potassium - Google Patents
Procédé, système et kit de détection de la concentration en ion potassium Download PDFInfo
- Publication number
- WO2013189265A1 WO2013189265A1 PCT/CN2013/077335 CN2013077335W WO2013189265A1 WO 2013189265 A1 WO2013189265 A1 WO 2013189265A1 CN 2013077335 W CN2013077335 W CN 2013077335W WO 2013189265 A1 WO2013189265 A1 WO 2013189265A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wavelength
- solution
- sample
- concentration
- buffer
- Prior art date
Links
- 229910001414 potassium ion Inorganic materials 0.000 title claims abstract description 189
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 title claims abstract description 150
- 238000000034 method Methods 0.000 title claims abstract description 68
- 239000012085 test solution Substances 0.000 claims abstract description 155
- 239000000243 solution Substances 0.000 claims abstract description 129
- 238000002835 absorbance Methods 0.000 claims abstract description 78
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 27
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 239000012895 dilution Substances 0.000 claims abstract description 17
- 238000010790 dilution Methods 0.000 claims abstract description 17
- 230000005284 excitation Effects 0.000 claims abstract description 14
- 230000031700 light absorption Effects 0.000 claims abstract description 12
- 108020004414 DNA Proteins 0.000 claims description 113
- 239000000872 buffer Substances 0.000 claims description 102
- 108091081406 G-quadruplex Proteins 0.000 claims description 52
- 239000000975 dye Substances 0.000 claims description 44
- 102000053602 DNA Human genes 0.000 claims description 33
- 229910001415 sodium ion Inorganic materials 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 150000002500 ions Chemical class 0.000 claims description 20
- -1 halogen anion Chemical class 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Natural products CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 150000001721 carbon Chemical group 0.000 claims description 10
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 claims description 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 9
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 9
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 9
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 229910021538 borax Inorganic materials 0.000 claims description 7
- 239000004328 sodium tetraborate Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 159000000000 sodium salts Chemical class 0.000 claims description 5
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 claims description 4
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 102000055501 telomere Human genes 0.000 claims description 4
- 108091035539 telomere Proteins 0.000 claims description 4
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 239000007983 Tris buffer Substances 0.000 claims description 3
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims description 3
- 125000003944 tolyl group Chemical group 0.000 claims description 3
- 229960002319 barbital Drugs 0.000 claims description 2
- CSVGEMRSDNSWRF-UHFFFAOYSA-L disodium;dihydrogen phosphate Chemical compound [Na+].[Na+].OP(O)([O-])=O.OP(O)([O-])=O CSVGEMRSDNSWRF-UHFFFAOYSA-L 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 239000012064 sodium phosphate buffer Substances 0.000 claims description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 claims description 2
- OTNVGWMVOULBFZ-UHFFFAOYSA-N sodium;hydrochloride Chemical compound [Na].Cl OTNVGWMVOULBFZ-UHFFFAOYSA-N 0.000 claims description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 229910052714 tellurium Inorganic materials 0.000 claims 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 230000003139 buffering effect Effects 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 246
- 210000002700 urine Anatomy 0.000 description 123
- 239000012086 standard solution Substances 0.000 description 57
- 239000011734 sodium Substances 0.000 description 53
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- 239000012488 sample solution Substances 0.000 description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- 210000002966 serum Anatomy 0.000 description 24
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 21
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 17
- 238000001514 detection method Methods 0.000 description 17
- 239000011591 potassium Substances 0.000 description 17
- 229910052700 potassium Inorganic materials 0.000 description 15
- 239000001007 phthalocyanine dye Substances 0.000 description 14
- 230000008859 change Effects 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 238000000862 absorption spectrum Methods 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 239000012452 mother liquor Substances 0.000 description 9
- 238000010835 comparative analysis Methods 0.000 description 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 7
- 238000000691 measurement method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000005048 flame photometry Methods 0.000 description 5
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000010413 mother solution Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 0 C*CCC(CCN1c(c(cccc2)c2cc2)c2SC1=CC(C)=Cc1*(CCCS(O)(=O)=O)c(C2=C(C(C)C3)C=CCC2C)c3[s]1)S(O)(=O)=O Chemical compound C*CCC(CCN1c(c(cccc2)c2cc2)c2SC1=CC(C)=Cc1*(CCCS(O)(=O)=O)c(C2=C(C(C)C3)C=CCC2C)c3[s]1)S(O)(=O)=O 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000002682 Hyperkalemia Diseases 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000010812 external standard method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000010813 internal standard method Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 description 2
- 235000011151 potassium sulphates Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 241000220479 Acacia Species 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000008876 conformational transition Effects 0.000 description 1
- 239000002633 crown compound Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 238000004750 isotope dilution mass spectroscopy Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000003663 ventricular fibrillation Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/06—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups three >CH- groups, e.g. carbocyanines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Definitions
- Ion-selective electrode method Determination of potassium and sodium ions in serum and urine on a dedicated instrument. Because it has the advantages of low sample consumption, fast and accurate, and easy operation, it is the most convenient and accurate method among all the current methods, and there is almost a tendency to replace other methods.
- the principle is:
- the ion selective electrode is an electrochemical sensor with a sensitive membrane electrode that selectively responds to specific ions, converting the ion activity into a potential signal, within a certain range, its potential and solution.
- the logarithm of the specific ion activity is linear.
- the ion activity of the unknown solution can be obtained by comparison with the solution of the known ion concentration. According to the measurement process, it is divided into the direct measurement method and the indirect measurement method. The measurement method is performed by diluting the sample to be tested by an indirect measurement method, and the measured ion activity is closer to the ion concentration.
- Enzymatic method The principle of enzymatic determination of potassium is to use the activation of pyruvate kinase, which catalyzes the conversion of phosphoenolpyruvate to lactic acid accompanied by the consumption of reduced coenzyme I, and measures NADH at a wavelength of 340 nm. The absorbance drops.
- the excitation intensity of the wavelength at the third wavelength is detected using an excitation wavelength of 560 nm, wherein the first wavelength is in the range of 560 nm to 590 nm, and the second wavelength is in the range of 500 nm to 540 nm, and the third wavelength is 580nm to 640nm range;
- step (4) placing the test solution obtained in the step (4) under an ultraviolet visible light absorption spectrometer or a spectrophotometer, Detecting the absorbance value of the test solution at the first wavelength and the second wavelength, or placing the test solution under a fluorescence spectrometer, and detecting the fluorescence intensity value at the third wavelength by using an excitation wavelength of 560 nm;
- a second aspect of the invention provides a method of detecting potassium ion concentration in a liquid sample in the context of sodium ions, the method comprising the steps of:
- each of the solution samples contains the same concentration of a DNA molecule capable of forming a G-quadruplex, the same concentration of sodium Ions and the same concentration of cyanine dyes;
- the fluorescence intensity value of the wavelength at the third wavelength is detected by a fluorescence spectrometer using an excitation wavelength of 560 nm, wherein the first wavelength is in the range of 560 nm to 590 nm, and the fourth wavelength is in the range of 610 nm to 670 nm, the third wavelength In the range of 580 nm to 640 nm;
- a third aspect of the invention provides a method of detecting a range of potassium ion concentrations in a liquid sample, the method comprising the steps of:
- the buffer is selected from the group consisting of tris buffer, hydrochloric acid-borax buffer, triethanolamine buffer, imidazole-hydrochloric acid buffer, and glycine buffer Or 2-amino-2-methyl- ⁇ propanol buffer.
- the buffer is selected from the group consisting of trishydroxymethylaminomethane
- the concentration of the buffer in the buffer is not particularly limited, but a preferred concentration range is 10 to 50 mmol/L.
- R 6 is alkyl, phenyl, alkyl-substituted phenyl
- R 2, R 3, and R 5 are independently selected from H or dC 6 alkyl, or R 2 and R 3 are attached to them
- the carbon atoms together form a 5- to 7-membered ring structure, or form a 5- to 7-membered ring structure together with R 5 and the carbon atom to which they are attached
- R 7 is a dC 6 alkyl or sulfonate substituted dC 6 alkyl
- Y is a counter ion, and varies according to the charge of R 7 .
- R 7 is an alkyl group
- Y is a halogen anion; if only one of R 7 has a sulfonate, Y is not required.
- a counterion if both R 7 and a sulfonate, Y is a triethylamine cation;
- Xi, X 2 is independently selected from carbon (C), oxygen (0), sulfur (S), selenium (Se) or ⁇ (Te).
- the method according to the first, second and third aspects of the invention which is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, iso Butyl, n-hexyl, isohexyl, phenyl, methylphenyl or dimethylphenyl.
- R 2 , R 3 , and R 5 are independently selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, and iso Butyl, tert-butyl, pentyl, isopentyl, n-hexyl or isohexyl.
- the plurality of solution samples can be formulated by using a soluble potassium salt such as potassium chloride, potassium sulfate, potassium nitrate or the like, potassium ions in each solution sample Concentration
- a soluble potassium salt such as potassium chloride, potassium sulfate, potassium nitrate or the like
- potassium ions in each solution sample Concentration The range is preferably in the range of 0 to 300 mmol/L, further preferably in the range of 0 to 200 mmol/L, still more preferably in the range of 0 to 150 mmol/L, and most preferably in the range of 20 to 100 mmol/L, wherein
- Non-limiting examples of soluble potassium salts include potassium chloride, potassium bromide, potassium iodide, potassium sulfate or potassium nitrate.
- the concentration of sodium ions may be adjusted by adding a soluble sodium salt or using a buffer containing sodium ions, non-limiting examples of which include , sodium chloride, sodium bromide, sodium iodide, sodium sulfate or sodium nitrate.
- the concentration of the cyanine dye in the solution sample is in the range of 3 to 20 ⁇ m ⁇ 1 / ⁇ , preferably 5 to ⁇ / ⁇ , which is capable of forming G
- concentration of the tetra-stranded DNA molecule in the solution sample is in the range of 3 to 30 ⁇ m ⁇ 1 / ⁇ , preferably 5 to 20 ⁇ 1 / ⁇ , and further preferably 10 to 20 ⁇ 1 / ⁇ .
- TTAGGGTTAGGG TTAGGGTTAGGG, TTAGGGTTAGGGTTAGGGTTAGGGTTAGGG, AGGGTTAGGGTTAGGGTTAGGG, TGAGGGTGGGGAGGGTGGGGAA, AGGGAGGGCGCTGGGAGGAGGG, GGGCGCGGGAGGAATTGGGCGGG, GGTTGGTGTGGTTGG, TTGGGGTTGGGGTTGGGG, TTGGGGTTGGGG, GGGGTTGGGG, GGGCGCGGGAGGAAGGGGGCGGG or
- a DNA molecule such as GGGCGCGGGAGGAATTGGGCGGG, but the range of DNA sequence ⁇ ij which can form a G-quadruplex is not limited by these enumerations.
- the length of the DNA molecule capable of forming a G-quadruplex used in the present invention is not particularly limited, but is preferably 6 300 bases in length, more preferably 10 100 bases in length, and most preferably 10 30 The length of each base.
- a fourth aspect of the present invention provides a kit for carrying out the method of the present invention, the kit comprising: a buffer having a pH of 6.2 to 8.2, a soluble potassium salt, a DNA molecule capable of forming a G-quadruplex, and a cyanine dye.
- the kit according to the fourth aspect of the present invention further comprising a standard color chart, wherein different colors in the standard color chart correspond to different potassium ion concentrations.
- the color on the standard color chart can be determined by: (i) preparing a plurality of solution samples having different potassium ion concentrations using a buffer solution having a pH of 6.2 to 8.2, so that each of the solution samples contains the same concentration of a DNA molecule capable of forming a G quadruplex, and the same concentration of sodium ions.
- the preparation method can be referred to the synthetic route described in Leslie GS, Brooker and Frank LW, JACS, 1935, 547-551, or may be used. Other methods well known in the art are prepared.
- a fifth aspect of the invention provides a system for carrying out the method of the first and second aspects of the invention, the system comprising the kit of the fourth aspect of the invention and an ultraviolet visible light absorption spectrometer or a spectrophotometer or a fluorescence spectrometer.
- the present invention uses a cyanine dye supramolecular probe, which is sensitive to the change of potassium-regulated G-quadruplex structure, accompanied by a change in aggregate morphology, and exhibits an absorption band up to a displacement of nearly one hundred nanometers in the ultraviolet absorption spectrum. , thus producing a change in color, enabling visual detection;
- the cyanine dye supramolecules used in the present invention can produce significant changes in both ultraviolet absorption spectrum and fluorescence spectrum, and can be quantitatively detected by an ordinary ultraviolet absorption spectrometer or a spectrophotometer or a fluorescence spectrometer, and no special or additional instruments are required. , the test cost is low, and it is convenient for promotion and application in the industry;
- the reagent components used in the present invention are only 3 to 4 kinds, and can be detected by instruments only when mixed in proportion, and the operation is simple, quick, and low in cost, and the system operates in a buffer environment without polluting the environment.
- the reagents used in the invention are simple in composition, small in variety, have no influence on each other, and have good stability, and can be stored for a long time, which can ensure the application test effect well;
- FIG. 1 is a potassium ion concentration standard curve according to Example 1 of the present invention.
- Figure 2 is a standard curve of potassium ion concentration according to Example 2 of the present invention.
- Figure 3 is a standard curve of potassium ion concentration according to Example 3 of the present invention.
- Figure 4 is a standard curve of potassium ion concentration according to Example 4 of the present invention.
- Figure 5 is a potassium ion concentration standard curve according to Example 9 of the present invention.
- FIG 8 is a standard curve of potassium ion concentration according to Example 12 of the present invention.
- the present invention will be described in more detail by way of specific embodiments thereof with reference to the accompanying drawings. The present invention may be practiced by those skilled in the art, and the scope of the invention should not be limited to the specific embodiments set forth herein.
- the instruments used in the examples of the present invention are: UV-visible absorption spectrometer, model Agilent 8453 UV-visible spectrophotometer; fluorescence spectrometer, model Hitachi F4500 spectrofluorometer (Japan).
- the DNA capable of forming a G-quadruplex used in the present example is AGGGTTAGGGTTAGGGTTAGGG, and the cyanine dye used is a compound of the following formula
- a certain amount of DNA was dissolved in Tris-HCl buffer at pH 6.2 to prepare a mother liquor at a concentration of 200 ⁇ / ⁇ DNA for use.
- the above samples were each analyzed by an ultraviolet absorption spectrometer. Everything is done at room temperature without additional conditions.
- the ultraviolet absorption spectrum collects data at a wavelength of 400 to 800 nm.
- the absorbance (at the 580 nm) of the standard sample is plotted on the abscissa and the potassium ion concentration of the standard sample is plotted on the ordinate to obtain a standard curve of the potassium ion concentration, as shown in Fig. 1.
- the potassium ion concentration of the corresponding test solution can be found on the standard curve, and this value is divided by 1% to obtain the potassium ion concentration value of the urine sample to be tested.
- Table 1 The results are shown in Table 1 below.
- the DNA which can be used to form the G quadruplex in this example is TGAGGGTGGGG
- a certain amount of DNA was dissolved in a boric acid-borax buffer solution having a pH of 8.2 to prepare a mother liquor having a concentration of 200 ⁇ m ⁇ 1 / ⁇ DNA, and was used.
- the above samples were each analyzed by an ultraviolet absorption spectrometer. Everything is done at room temperature without additional conditions.
- the ultraviolet absorption spectrum collects data at a wavelength of 400 to 800 nm.
- the DNA which can be used to form the G four chain in this example is GGGCCAGGGAG compound.
- the above samples were each analyzed by an ultraviolet absorption spectrometer. Everything is done at room temperature without additional conditions.
- the ultraviolet absorption spectrum collects data at a wavelength of 400 to 800 nm.
- the DNA capable of forming a G quadruplex used in the present example is AGGGTT, and the cyanine dye used is a compound of the following formula
- a certain amount of DNA was dissolved in a pH 7.0 7.0 Tris-HCl buffer to prepare a 1.2 mmol/L DNA stock solution for use.
- the fluorescence intensity (FI) at a wavelength of 580 nm of the standard sample is plotted on the abscissa and the potassium ion concentration of the standard sample is plotted on the ordinate to obtain a standard curve of the potassium ion concentration, as shown in FIG.
- FI fluorescence intensity
- the fluorescence intensity of the test solution find the potassium ion concentration value of the corresponding test solution on the standard curve, and divide it by 1% to obtain the potassium ion concentration value of the urine sample to be tested. The results are shown in Table 4 below.
- the absorbance of the solution sample and the test solution at a wavelength of 590 nm was measured and recorded as .
- the absorbances of the solution sample and the test solution at a wavelength of 590 nm and 540 nm were measured and recorded as A 2 , respectively.
- the concentration of the sample to be tested is A 2 , the concentration of mmol/L, the actual concentration of mmol/L.
- Example 9-16 was carried out in the background of sodium ions
- the DNA which can be used to form the G-quadruplex in the present example is AGGGTTAGGGTTAGGGTTAGGG, and the cyanine dye used is a compound of the following formula.
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer (pH 6.2) containing 20 mmol/L NaCl, and a DNA mother solution having a concentration of 500 ⁇ m ⁇ 1/ ⁇ was prepared and used.
- Tris-Na solution with a concentration of 200mmol/L KC1
- Tris-Na buffer to obtain potassium ions with concentrations of 0, 0.05, 0.1, 0.2. , 0.5, 1, 1.5 mmol / L of the standard sample solution.
- the above samples were analyzed by an ultraviolet absorption spectrometer. Everything is done at room temperature without additional conditions.
- the ultraviolet absorption spectrum collects data at a wavelength of 400 to 800 nm.
- Example 11 The DNA capable of forming a G quadruplex used in the present example is
- Tris-Na solution with a concentration of 200mmol/L KC1
- Tris-Na buffer to obtain potassium ions with concentrations of 0, 0.05, 0.1, 0.2. , 0.5, 1, 1.5 mmol / L of the standard sample solution.
- the above samples were analyzed by an ultraviolet absorption spectrometer. Everything is done at room temperature without additional conditions.
- the ultraviolet absorption spectrum collects data at a wavelength of 400 to 800 nm.
- the ratio of the absorbance ( ) at 560 nm of the standard sample to the absorbance (A 3 ) at 670 nm ( / A 3 ) is plotted on the abscissa, and the potassium ion concentration of the standard solution sample is plotted on the ordinate to obtain the standard of potassium ion concentration.
- the curve is shown in Figure 7.
- the potassium ion concentration of the corresponding test solution can be found on the standard curve, and this is divided by 1% to obtain the potassium of the urine sample to be tested.
- the ion concentration values are shown in Table 11 below.
- the concentration of the sample to be tested is obtained by At/A 3 mmol/L actual concentration mmol/L urine sample 1 28. 37 31. 17 Urine sample 2 36. 76 39. 71
- the G-quadruplex can be formed in this embodiment.
- the cyanine dye used is a compound of the formula
- a certain amount of DNA was dissolved in Tris-HCl (Tris-Na) buffer containing 40 mmol/L NaCl to prepare a DNA mother liquor at a concentration of 3 mmol/L, and was used.
- Tris-Na solution with a concentration of 200mmol/L KC1
- Tris-Na buffer to obtain potassium ions with concentrations of 0, 0.05, 0.1, 0.2. , 0.5, 1, 1.5 mmol / L of the standard sample solution.
- the above samples were analyzed by a fluorescence spectrometer. Everything is done at room temperature without additional conditions.
- the fluorescence spectrum has an excitation wavelength of 560 nm and a wavelength collection range of 570 to 720 nm.
- the fluorescence intensity of the standard sample at 640 nm (denoted as FI) is plotted on the abscissa and the potassium ion concentration of the standard solution sample is plotted on the ordinate to obtain a standard curve of potassium ion concentration, as shown in Fig. 8.
- the potassium ion concentration value of the corresponding test solution can be found on the standard curve, and it is divided by 1% to obtain the potassium ion concentration value of the urine sample to be tested.
- Table 12 The results are shown in Table 12 below.
- the concentration of the sample to be tested is obtained by FI.
- the concentration of mmol/L is actually the concentration of mmol/L.
- the absorbance of the solution sample and the test solution at a wavelength of 590 nm was measured and recorded.
- the absorbance of the solution sample and the test solution at a wavelength of 670 nm was measured and recorded as A 3 .
- the fluorescence intensity of the solution sample and the test solution at a wavelength of 600 nm was measured and recorded as FI.
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer (pH 8.0) containing 20 mmol/L NaCl, and a DNA mother solution having a concentration of ⁇ /L was prepared and used.
- Tris-HCl Tris-Na
- pH 8.0 Tris-Na buffer
- the potassium ion concentration of three urine samples was verified.
- the actual potassium ion concentration of each urine sample was as follows: urine sample 1 was 9.18 mmol/L, urine sample 2 was 32.43 mmol/L, urine sample 3 was 49.57 mmol. /L.
- the DNA capable of forming a G-quadruplex used in the present example is AGGGTTAGGGTTAGGGTTAGGG, the cyanine dye used.
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer (pH 6.2) containing 40 mmol/L NaCl to prepare a DNA mother solution at a concentration of 500 ⁇ m ⁇ 1/ ⁇ , and was used.
- Tris-HCl Tris-Na buffer (pH 6.2) containing 40 mmol/L NaCl to prepare a DNA mother solution at a concentration of 500 ⁇ m ⁇ 1/ ⁇ , and was used.
- the potassium ion concentration of three urine samples was verified.
- the actual potassium ion concentration of each urine sample was as follows: urine sample 1 was 9.82 mmol/L, urine sample 2 was 20.35 mmol/L, and urine sample 3 was 78.26. Mmmol/L.
- the DNA which can be used to form a G-quadruplex in this example is TTAGGG TTAGGGTTAGG
- the color of the test solution was compared with the color of the standard solution sample, and it was found that the colors of the test solutions 1 and 2 were blue, and the color of the test solution 3 was purple. Therefore, the potassium ion concentration of the test solutions 1, 2, 3 is in the range of 0-60, and the potassium ion concentration of the urine samples 1, 2, 3 can be obtained in the range of 0 to 80 by dilution ratio conversion. This result is in agreement with the actual concentration of the urine sample.
- the potassium ion concentration of three urine samples was verified.
- the actual potassium ion concentration of each urine sample was as follows: urine sample 1 was 42.58 mmol/L, urine sample 2 was 70.65 mmol/L, and urine sample 3 was 98.34. Mmmol/L.
- the DNA capable of forming a G-quadruplex used in the present example is AGGGTTAGGGTTAGGGTTAGGG, the cyanine dye used.
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer (pH 8.2) containing 160 mmol/L NaCl to prepare a DNA mother liquor having a concentration of 500 ⁇ m ⁇ / ⁇ , and was used.
- Tris-HCl Tris-Na buffer (pH 8.2) containing 160 mmol/L NaCl to prepare a DNA mother liquor having a concentration of 500 ⁇ m ⁇ / ⁇ , and was used.
- Tris-Na solution with a concentration of 200mmol/L KC1
- Tris-Na buffer to obtain potassium ions with concentrations of 0, 20, 50, 75 respectively.
- 100, 125, 160 mmol / L standard sample solution The color of the standard solution sample is as follows: The color of the standard solution sample of 0 ⁇ 100mmol/L gradually changes from blue to purple, and the color of the standard solution of 100 ⁇ 125mmol/L gradually changes from purple to pink.
- the urine sample in each test solution accounted for 75% of the volume of the test solution.
- the color of the test solution was compared with the color of the standard solution sample, and it was found that the color of the test solution 1 was blue, and the color of the test solution 2 and the test solution 3 was purple. Therefore, the potassium ion concentration of the test solutions 1, 2, and 3 is in the range of 0 to 100.
- the dilution ratio can be used to obtain the potassium ion concentration of the urine samples 1, 2, and 3 in the range of 0 to 133, and the urine sample 2, 3 potassium.
- the ion concentration is higher than the urine sample 1 potassium ion concentration. This result is in agreement with the actual concentration of the urine sample.
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer (pH 7.0) containing 20 mmol/L NaCl to prepare a DNA mother solution having a concentration of 20 (mol/L), which was used.
- Tris-HCl Tris-Na buffer (pH 7.0) containing 20 mmol/L NaCl to prepare a DNA mother solution having a concentration of 20 (mol/L), which was used.
- the color of the test solution was compared with the color of the standard solution sample, and it was found that the color of the test solution 1 was blue, the test solution 2 was purple, and the color of the test solution 3 was pink. Therefore, the potassium ion concentration of the test solution 1 is in the range of 0 to 10, and the potassium ion concentration of the test solution 2 and the test solution 3 is in the range of 10 20 , and the potassium ion concentration of the urine sample 1 can be obtained from 0 to 20 by dilution ratio conversion.
- the range of urine sample 2 and urine sample 3 has a potassium ion concentration in the range of 20 to 40. This result is in agreement with the actual concentration of the urine sample.
- the potassium ion concentration of three urine samples was verified.
- the actual potassium ion concentration of each urine sample was as follows: urine sample 1 was 85.32 mmol/L, urine sample 2 was 100.54 mmol/L, urine sample 3 was 126.32 mmol. /L, the DNA used is GGGCGCGGGAGGAAGGGGGCGGG, and the cyanine dye used is a compound of the formula:
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer (pH 6.2) containing 300 mmol/L NaCl to prepare a DNA mother liquor having a concentration of 20 (mol/L), which was used.
- Tris-HCl Tris-Na buffer (pH 6.2) containing 300 mmol/L NaCl to prepare a DNA mother liquor having a concentration of 20 (mol/L), which was used.
- the color of the test solution was compared with the color of the standard solution sample, and it was found that the colors of the test solutions 1, 2, and 3 were blue. Therefore, the potassium ion concentration of the test solutions 1, 2, 3 is in the range of 0 150, and the potassium ion concentration of the three urine samples is in the range of 0 300 by the dilution ratio conversion. This result is in agreement with the actual concentration of the urine sample.
- a certain amount of DNA sample was dissolved in Tris-HCl (Tris-Na) buffer ( ⁇ 8.0) containing 10 mmol/L NaCl to prepare a DNA mother solution having a concentration of 200 ⁇ m ⁇ 1/ ⁇ , and was used.
- test solution In the other three samples, 200 ⁇ of the urine sample to be tested was added to obtain three test solutions, and the urine sample in each test solution accounted for 17% of the volume of the test solution.
- the color of the test solution was compared with the color of the standard solution sample, and it was found that the color of the test solution 1 was blue, and the color of the test solution 2 and the test solution 3 was pink. Therefore, the potassium ion concentration of the test solution 1 is in the range of 0-6, and the potassium ion concentration of the test solution 2 and the test solution 3 is in the range of 6-10, and the potassium ion concentration of the urine sample 1 can be obtained by the dilution ratio conversion. In the range of 35, the potassium ion concentration of urine sample 2 and urine sample 3 is in the range of 35 to 59. This result is in agreement with the actual concentration of the urine sample.
- pH (pH 6.2) a DNA stock solution of ⁇ /L was prepared and used.
- Tris-Na solution with a concentration of 200mmol/L KC1
- Tris-Na buffer to obtain potassium ions with concentrations of 0, 10, 20, respectively. 30, 40, 50, 60 mmol/L standard sample solution.
- the color of the standard solution sample is as follows: The color of the standard solution sample of 0 ⁇ 30mmol/L gradually changes from blue to purple, and the color of the standard solution of 30 ⁇ 60mmol/L gradually changes from purple to pink.
- the color of the test solution 1 was found. In blue, the color of Test Solution 2 and Test Solution 3 is purple. Therefore, the potassium ion concentration of the test solution 1 is in the range of 0-30, and the potassium ion concentration of the test solution 2 and the test solution 3 is in the range of 30 60.
- the potassium ion concentration of the urine sample 1 can be obtained by the dilution ratio conversion from 0 to 45.
- the range of urine sample 2 and urine sample 3 has a potassium ion concentration in the range of 45 to 91. This result is in agreement with the actual concentration of the urine sample.
- One of the remarkable features of the present invention is: detection of changes in DNA conformation based on potassium ions, potassium ions cause DNA conformational changes, and DNA conformational changes cause changes in the aggregation pattern of cyanine dyes, resulting in solution color or absorption, fluorescence The spectrum changes.
- the system is simple in composition and simple in reaction. Potassium ion is the "initiator" of the whole reaction, which ensures the accuracy of the detection.
- the third characteristic feature of the present invention is that the use of a cyanine dye supramolecular probe has high reaction sensitivity and color change, and can be visually observed.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
La présente invention concerne un procédé de détection d'une concentration en ion potassium dans un échantillon liquide, comprenant les étapes consistant à : (1) formuler une pluralité d'échantillons en solution avec différentes concentrations en ion potassium avec une solution tampon à un pH de 6,2-8,2, chacun des échantillons en solution contenant des molécules d'ADN pouvant former des G-quadruplexes à la même concentration et un colorant cyanine à la même concentration ; (2) placer la pluralité d'échantillons en solution sous un spectromètre ou spectrophotomètre d'absorption dans l'ultraviolet/le visible, et détecter la valeur d'absorbance à une première longueur d'onde et la valeur d'absorbance à une deuxième longueur d'onde, ou placer la pluralité d'échantillons en solution sous un spectrophotomètre de fluorescence, et détecter la valeur d'intensité de fluorescence à une troisième longueur d'onde avec une longueur d'onde d'excitation de 560 nm, la première longueur d'onde étant la plage allant de 560 nm à 590 nm, la deuxième longueur d'onde étant dans la plage allant de 500 nm à 540 nm, et la troisième longueur d'onde étant dans la plage allant de 580 nm à 640 nm ; (3) représenter graphiquement la concentration en ion potassium de chacun des échantillons en solution en abscisse ou en ordonnée et la valeur d'absorbance à la première longueur d'onde ou la valeur d'absorbance à la deuxième longueur d'onde ou le rapport entre la valeur d'absorbance à la première longueur d'onde et la valeur d'absorbance à la deuxième longueur d'onde, ou la valeur d'intensité de fluorescence à la troisième longueur d'onde mesurée dans l'étapes (2) en ordonnée ou en abscisse, afin d'obtenir une courbe étalon de la concentration en ion potassium ; (4) ajouter des molécules d'ADN pouvant former des G-quadruplexes, un composé de formule I et une solution tampon dans un échantillon liquide à analyser, afin de permettre que les molécules d'ADN pouvant former des G-quadruplexes, le composé de formule I et la valeur de pH dans l'échantillon liquide à analyser correspondent à ceux des échantillons en solution dans l'étape (1), afin d'obtenir une solution d'essai ; (5) placer la solution d'essai obtenue dans l'étape (4) sous le spectromètre ou spectrophotomètre d'absorption dans l'ultraviolet/le visible et détecter les valeurs d'absorbance de la solution d'essai à la première longueur d'onde et à la deuxième longueur d'onde, ou placer la solution d'essai sous le spectrophotomètre de fluorescence, et détecter la valeur d'intensité de fluorescence à une troisième longueur d'onde avec une longueur d'onde d'excitation de 560 nm; (6) déterminer la concentration en ion potassium correspondante de la solution d'essai dans la courbe étalon de la concentration en ion potassium obtenue dans l'étape (3) en utilisant la valeur d'absorbance à la première longueur d'onde ou la valeur d'absorbance à la deuxième longueur d'onde, ou le rapport entre la valeur d'absorbance à la première longueur d'onde et la valeur d'absorbance à la deuxième longueur d'onde ou la valeur d'intensité de fluorescence à la troisième longueur d'onde mesurées dans l'étape (5), puis calculer la concentration en ion potassium de l'échantillon à analyser par le rapport de dilution de l'échantillon à analyser.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210207722.5A CN102735623B (zh) | 2012-06-18 | 2012-06-18 | 钾离子浓度检测试剂盒和系统 |
CN201210207722.5 | 2012-06-18 | ||
CN201210205861.4 | 2012-06-18 | ||
CN201210206227.2A CN102735664B (zh) | 2012-06-18 | 2012-06-18 | 钾离子浓度检测方法 |
CN201210205843.6 | 2012-06-18 | ||
CN201210206227.2 | 2012-06-18 | ||
CN201210205861.4A CN102866149B (zh) | 2012-06-18 | 2012-06-18 | 钾离子浓度检测试剂盒 |
CN201210205843.6A CN102866148B (zh) | 2012-06-18 | 2012-06-18 | 钾离子浓度检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013189265A1 true WO2013189265A1 (fr) | 2013-12-27 |
Family
ID=49768109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/077335 WO2013189265A1 (fr) | 2012-06-18 | 2013-06-17 | Procédé, système et kit de détection de la concentration en ion potassium |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013189265A1 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2850086A4 (fr) * | 2012-05-18 | 2016-03-09 | Pacific Biosciences California | Colorants hétéroarylcyanines |
US9315864B2 (en) | 2012-05-18 | 2016-04-19 | Pacific Biosciences Of California, Inc. | Heteroarylcyanine dyes with sulfonic acid substituents |
US9441270B2 (en) | 2010-08-25 | 2016-09-13 | Pacific Biosciences Of California, Inc. | Cyanine dyes |
CN110793925A (zh) * | 2019-10-22 | 2020-02-14 | 哈尔滨工业大学(深圳) | 一种铁氰化钾示差分光光度法测定连二亚硫酸盐方法 |
CN114112955A (zh) * | 2021-11-23 | 2022-03-01 | 福州大学 | 一种测量溶液中ez宽度的方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030198966A1 (en) * | 2002-04-19 | 2003-10-23 | Stojanovic Milan N. | Displacement assay for detection of small molecules |
CN101080497A (zh) * | 2003-12-16 | 2007-11-28 | 金伯利-克拉克环球有限公司 | 微生物检测与定量 |
CN102735664A (zh) * | 2012-06-18 | 2012-10-17 | 中国科学院化学研究所 | 钾离子浓度检测方法 |
CN102735623A (zh) * | 2012-06-18 | 2012-10-17 | 中国科学院化学研究所 | 钾离子浓度检测试剂盒和系统 |
CN102866149A (zh) * | 2012-06-18 | 2013-01-09 | 中国科学院化学研究所 | 钾离子浓度检测试剂盒 |
CN102866148A (zh) * | 2012-06-18 | 2013-01-09 | 中国科学院化学研究所 | 钾离子浓度检测方法 |
CN103048301A (zh) * | 2012-12-18 | 2013-04-17 | 中国科学院化学研究所 | 钠/钾离子比检测方法、系统和试剂盒 |
-
2013
- 2013-06-17 WO PCT/CN2013/077335 patent/WO2013189265A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030198966A1 (en) * | 2002-04-19 | 2003-10-23 | Stojanovic Milan N. | Displacement assay for detection of small molecules |
CN101080497A (zh) * | 2003-12-16 | 2007-11-28 | 金伯利-克拉克环球有限公司 | 微生物检测与定量 |
CN102735664A (zh) * | 2012-06-18 | 2012-10-17 | 中国科学院化学研究所 | 钾离子浓度检测方法 |
CN102735623A (zh) * | 2012-06-18 | 2012-10-17 | 中国科学院化学研究所 | 钾离子浓度检测试剂盒和系统 |
CN102866149A (zh) * | 2012-06-18 | 2013-01-09 | 中国科学院化学研究所 | 钾离子浓度检测试剂盒 |
CN102866148A (zh) * | 2012-06-18 | 2013-01-09 | 中国科学院化学研究所 | 钾离子浓度检测方法 |
CN103048301A (zh) * | 2012-12-18 | 2013-04-17 | 中国科学院化学研究所 | 钠/钾离子比检测方法、系统和试剂盒 |
Non-Patent Citations (2)
Title |
---|
HAIXIA QIN ET AL., G-QUADRULEX-MODULATED FLUORESCENCE DETECTION OF POTASSIUM IN THE PRESENCE OF A 3500-FOLD EXCESS OF SODIUM IONS, 1 October 2010 (2010-10-01) * |
SATORU NAGATOISHI ET AL., FLUORESCENCE ENERGY TRANSFER PROBES BASED ON THE GUANINE QUADRUPLEX FORMATION FOR THE FLUOROMETRIC DETECTION OF POTASSIUM ION, 15 August 2006 (2006-08-15) * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9441270B2 (en) | 2010-08-25 | 2016-09-13 | Pacific Biosciences Of California, Inc. | Cyanine dyes |
US9499862B2 (en) | 2010-08-25 | 2016-11-22 | Pacific Biosciences Of California, Inc. | Phospholinked dye analogs with an amino acid linker |
US9777320B2 (en) | 2010-08-25 | 2017-10-03 | Pacific Biosciences Of California, Inc. | Molecular adaptors for dye conjugates |
US9920365B2 (en) | 2010-08-25 | 2018-03-20 | Pacific Biosciences Of California, Inc. | Functionalized cyanine dyes (PEG) |
US10392659B2 (en) | 2010-08-25 | 2019-08-27 | Pacific Biosciences Of California, Inc. | Cyanine dyes |
US11624089B2 (en) | 2010-08-25 | 2023-04-11 | Pacific Biosciences Of California, Inc. | Cyanine dyes |
EP2850086A4 (fr) * | 2012-05-18 | 2016-03-09 | Pacific Biosciences California | Colorants hétéroarylcyanines |
US9315864B2 (en) | 2012-05-18 | 2016-04-19 | Pacific Biosciences Of California, Inc. | Heteroarylcyanine dyes with sulfonic acid substituents |
US10458915B2 (en) | 2012-05-18 | 2019-10-29 | Pacific Biosciences Of California, Inc. | Heteroarylcyanine dyes |
CN110793925A (zh) * | 2019-10-22 | 2020-02-14 | 哈尔滨工业大学(深圳) | 一种铁氰化钾示差分光光度法测定连二亚硫酸盐方法 |
CN114112955A (zh) * | 2021-11-23 | 2022-03-01 | 福州大学 | 一种测量溶液中ez宽度的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102735664B (zh) | 钾离子浓度检测方法 | |
CN102866148B (zh) | 钾离子浓度检测方法 | |
CN102735623B (zh) | 钾离子浓度检测试剂盒和系统 | |
Zhou et al. | Design principles of spectroscopic probes for biological applications | |
WO2013189265A1 (fr) | Procédé, système et kit de détection de la concentration en ion potassium | |
CN103048301B (zh) | 钠/钾离子比检测方法、系统和试剂盒 | |
CN104596959A (zh) | 一种基于dna酶检测钾离子浓度的方法 | |
CN103063629B (zh) | 检测钠/钾离子比的方法和试剂盒以及系统 | |
WO2021180129A1 (fr) | Procédé de référence de mesure de teneur en protéine basé sur un comptage de molécule unique de type à flux par marquage par fluorescence | |
CN102914539A (zh) | 一种钼锑抗光度法检测水中正磷酸盐含量的方法及试剂盒 | |
CN102809651B (zh) | 肌酸磷酸激酶同工酶化学发光免疫定量检测试剂盒及其制备方法 | |
CN103472047B (zh) | 一种不同pH值下氨基酸的荧光检测方法 | |
CN103048282B (zh) | 一种胆红素的检测方法及检测试剂盒 | |
CN102866149B (zh) | 钾离子浓度检测试剂盒 | |
Golchini et al. | Synthesis and characterization of a new fluorescent probe for measuring potassium | |
CN104111244B (zh) | 一种荧光检测银离子含量的方法 | |
Lu et al. | An endo-functionalized molecular cage for selective potentiometric determination of creatinine | |
Nie et al. | New two dimensional liquid-phase colorimetric assay based on old iodine–starch complexation for the naked-eye quantitative detection of analytes | |
CN104569431A (zh) | 一种快速定量检测肌钙蛋白i的均相荧光免疫试剂组及其制备方法 | |
CN101477059B (zh) | 快速检测水溶液中无机磷的方法 | |
CN110964044B (zh) | 一种基于双香豆素衍生物的过氧化亚硝酸盐荧光探针、制备方法与应用 | |
CN108169196B (zh) | 一种快速检测环境中氟离子的方法 | |
CN103115904B (zh) | 尿微量白蛋白检测方法、系统和试剂盒 | |
CN105651746A (zh) | 基于硫黄素t染料设计的无标记荧光探针检测碘离子的方法 | |
CN116642868A (zh) | 一种稀土配合物荧光探针在检测2,6-吡啶二羧酸中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13807654 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13807654 Country of ref document: EP Kind code of ref document: A1 |